Charts for Quick CASH $$$ Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (4769)	10/30/1997 11:10:00 PM
From: John Metcalf	Read Replies (1) of 9262

[ SHMN ] Hi, Ray, excuse me for butting in. Shaman did not show strong results. AIDS diarrhea is one of the opportunistic infection niches that are dwindling due to more effective treatment against HIV. Stronger companies than Shaman have lost value because their products just won't be needed as often (GILD, for example). In the second study, efficacy was not demonstrated at a clinically significant level (simply put, they still had diarrhea four days later). Shaman has decided to focus on other indications, and has diluted shareholders recently. The appearance of bait and switch following a secondary offer is bothersome to some.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next